102

Lincoln, Nebraska

0 studies enrolling now · 2 studies all time

What they study most

Rheumatoid Arthritis

Studies at this site

• Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy — Completed
• Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 — Stopped early